Literature DB >> 18668213

Homeostatic control of B lymphocyte subsets.

Jenni E Crowley1, Jean L Scholz, William J Quinn, Jason E Stadanlick, John F Treml, Laura S Treml, Yi Hao, Radhika Goenka, Patrick J O'Neill, Andrew H Matthews, Ronald F Parsons, Michael P Cancro.   

Abstract

Lymphocyte homeostasis poses a multi-faceted biological puzzle, because steady pre-immune populations must be maintained at an acceptable steady state to yield effective protection, despite stringent selective events during their generation. In addition, activated, memory and both short- and long-term effectors must be governed by independent homeostatic mechanisms. Finally, advancing age is accompanied by substantial changes that impact the dynamics and behavior of these pools, leading to cumulative homeostatic perturbations and compensation. Our laboratory has focused on the over-arching role of BLyS family ligands and receptors in these processes. These studies have led to a conceptual framework within which distinct homeostatic niches are specified by BLyS receptor signatures, which define the BLyS family ligands that can afford survival. The cues for establishing these receptor signatures, as well as the downstream survival mechanisms involved, are integrated with cell extrinsic inputs via cross talk among downstream mediators. A refined understanding of these relationships should yield insight into the selection and maintenance of B cell subsets, as well as an appreciation of how homeostatic mechanisms may contribute to immunosenescence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668213      PMCID: PMC2662706          DOI: 10.1007/s12026-008-8036-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  58 in total

1.  A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice.

Authors:  D J Miller; K D Hanson; J A Carman; C E Hayes
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

2.  Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice.

Authors:  D J Miller; C E Hayes
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

3.  Connecting the dots: revealing the interactions of lymphocyte development and homeostasis in the immunobiology of aging.

Authors:  Michael P Cancro; David M Allman
Journal:  Semin Immunol       Date:  2005-10       Impact factor: 11.130

Review 4.  Space, selection, and surveillance: setting boundaries with BLyS.

Authors:  Juli P Miller; Jason E Stadanlick; Michael P Cancro
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

5.  Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1.

Authors:  Xiangao Huang; Maurizio Di Liberto; Adam F Cunningham; Lin Kang; Shuhua Cheng; Scott Ely; Hsiou-chi Liou; Ian C M Maclennan; Selina Chen-Kiang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

6.  Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.

Authors:  Sarah G Hymowitz; Darshana R Patel; Heidi J A Wallweber; Steven Runyon; Minhong Yan; Jianping Yin; Stephanie K Shriver; Nathaniel C Gordon; Borlan Pan; Nicholas J Skelton; Robert F Kelley; Melissa A Starovasnik
Journal:  J Biol Chem       Date:  2004-11-12       Impact factor: 5.157

7.  Receptor editing in self-reactive bone marrow B cells.

Authors:  S L Tiegs; D M Russell; D Nemazee
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

8.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

9.  Identification of proteoglycans as the APRIL-specific binding partners.

Authors:  Karine Ingold; Adrian Zumsteg; Aubry Tardivel; Bertrand Huard; Quynh-Giao Steiner; Teresa G Cachero; Fang Qiang; Leonid Gorelik; Susan L Kalled; Hans Acha-Orbea; Paul D Rennert; Jürg Tschopp; Pascal Schneider
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  Receptor editing: an approach by autoreactive B cells to escape tolerance.

Authors:  D Gay; T Saunders; S Camper; M Weigert
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  14 in total

1.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

Review 2.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

Review 3.  New roles for the BLyS/BAFF family in antigen-experienced B cell niches.

Authors:  Radhika Goenka; Jean L Scholz; Vishal J Sindhava; Michael P Cancro
Journal:  Cytokine Growth Factor Rev       Date:  2014-01-10       Impact factor: 7.638

Review 4.  B cells in chronic graft-versus-host disease.

Authors:  William McManigle; Ayman Youssef; Stefanie Sarantopoulos
Journal:  Hum Immunol       Date:  2019-03-05       Impact factor: 2.850

Review 5.  B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.

Authors:  Ronald F Parsons; Kumar Vivek; Robert R Redfield; Thi-Sau Migone; Michael P Cancro; Ali Naji; Hooman Noorchashm
Journal:  Transplant Rev (Orlando)       Date:  2010-07-23       Impact factor: 3.943

6.  Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages.

Authors:  David L Lamar; Cornelia M Weyand; Jörg J Goronzy
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

7.  BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.

Authors:  Luis Sanchez-Perez; Bryan D Choi; Elizabeth A Reap; Elias J Sayour; Pamela Norberg; Robert J Schmittling; Gerald E Archer; James E Herndon; Duane A Mitchell; Amy B Heimberger; Darell D Bigner; John H Sampson
Journal:  Cancer Immunol Immunother       Date:  2013-04-17       Impact factor: 6.968

8.  Cell-autonomous role for NF-kappa B in immature bone marrow B cells.

Authors:  Estefania Claudio; Sun Saret; Hongshan Wang; Ulrich Siebenlist
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

9.  APRIL mediates peritoneal B-1 cell homeostasis.

Authors:  Vishal J Sindhava; Jean L Scholz; William Stohl; Michael P Cancro
Journal:  Immunol Lett       Date:  2014-02-07       Impact factor: 3.685

Review 10.  Cracking the BAFF code.

Authors:  Fabienne Mackay; Pascal Schneider
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.